Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

The association between 25-hydroxy vitamin D deficiency and diabetic complications in patients with type 2 diabetes mellitus.

Senyigit A.

Diabetes Metab Syndr. 2019 Mar - Apr;13(2):1381-1386. doi: 10.1016/j.dsx.2019.01.043. Epub 2019 Feb 15.

PMID:
31336496
2.
3.

Effects of Quercetin on Lipid and Protein Damage in the Liver of Streptozotocin-Induced Experimental Diabetic Rats.

Senyigit A, Durmus S, Mirzatas EB, Ozsobacı NP, Gelisgen R, Tuncdemir M, Ozcelik D, Simsek G, Uzun H.

J Med Food. 2019 Jan;22(1):52-56. doi: 10.1089/jmf.2018.0030. Epub 2018 Oct 4.

PMID:
30285538
4.

Glucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes.

Senyigit A, Tabak O, Orhanoglu T, Karadag A, Ugurlu S, Uzun H, Konukoglu D.

Clin Invest Med. 2017 Oct 19;40(5):E188-E199. doi: 10.25011/cim.v40i5.28624.

PMID:
29061224
5.

The relationship between circulating irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome.

Tabak O, Simsek G, Erdenen F, Sozer V, Hasoglu T, Gelisgen R, Altunoglu E, Muderrisoglu C, Senyigit A, Uzun H.

Arch Endocrinol Metab. 2017 Dec;61(6):515-523. doi: 10.1590/2359-3997000000289. Epub 2017 Sep 18.

6.

The clinical factors associated with benefit finding of complementary medicine use in patients with back pain: A cross-sectional study with cluster analysis.

Kavadar G, Demircioğlu DT, Can H, Emre TY, Civelek E, Senyigit A.

J Back Musculoskelet Rehabil. 2017;30(2):271-277. doi: 10.3233/BMR-150470.

PMID:
27689602
7.

Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.

Demir M, Kaya H, Taylan M, Ekinci A, Yılmaz S, Teke F, Sezgi C, Tanrikulu AC, Meteroglu F, Senyigit A.

Lung. 2016 Jun;194(3):409-17. doi: 10.1007/s00408-016-9868-1. Epub 2016 Mar 31.

PMID:
27032653
8.

Low lipase levels as an independent marker of pancreatic cancer: a frequently neglected condition in clinical setting.

Gültepe İ, Başaranoğlu M, Zorlu M, Şenyiğit A, Taşkale EZ, Zaralı S, Atay K, Köroğlu E.

Turk J Gastroenterol. 2016 Mar;27(2):197-200. doi: 10.5152/tjg.2016.16056.

9.

PET/CT positive in a case with eosinophilic granuloma.

Demir M, Meteroğlu F, Kaya H, Taylan M, Yenibertiz D, Yılmaz S, Şenyiğit A.

Tuberk Toraks. 2015 Sep;63(3):207-9. No abstract available.

10.

Fibulin-3 as a diagnostic biomarker in patients with malignant mesothelioma.

Kaya H, Demir M, Taylan M, Sezgi C, Tanrikulu AC, Yilmaz S, Bayram M, Kaplan I, Senyigit A.

Asian Pac J Cancer Prev. 2015;16(4):1403-7.

11.

Is a complete blood cell count useful in determining the prognosis of pulmonary embolism?

Sen HS, Abakay O, Tanrikulu AC, Sezgi C, Taylan M, Abakay A, Kaya H, Senyigit A.

Wien Klin Wochenschr. 2014 Jun;126(11-12):347-54. doi: 10.1007/s00508-014-0537-1. Epub 2014 Mar 25.

PMID:
24664312
12.

Clinical characteristics, treatment and survival outcomes in malignant pleural mesothelioma: an institutional experience in Turkey.

Kucukoner M, Ali Kaplan M, Inal A, Urakci Z, Abakay O, Cetin Tanrikulu A, Abakay A, Selim Sen H, Turkcu G, Senyigit A, Buyukbayram H, Isikdogan A.

J BUON. 2014 Jan-Mar;19(1):164-70.

13.

Oxidative status and acute phase reactants in patients with environmental asbestos exposure and mesothelioma.

Sezgi C, Taylan M, Sen HS, Evliyaoğlu O, Kaya H, Abakay O, Abakay A, Tanrıkulu AC, Senyiğit A.

ScientificWorldJournal. 2014 Jan 23;2014:902748. doi: 10.1155/2014/902748. eCollection 2014.

14.

Two cases of extrapulmonary onset granulomatosis with polyangiitis which caused diffuse alveolar haemorrhage.

Kaya H, Yilmaz S, Sezgi C, Abakay O, Taylan M, Sen H, Demir M, Akkurt ZM, Senyigit A.

Respir Med Case Rep. 2014 Sep 16;13:32-6. doi: 10.1016/j.rmcr.2014.09.002. eCollection 2014.

15.

Effects of treatment regimens on survival in patients with malignant pleural mesothelioma.

Abakay A, Abakay O, Tanrikulu AC, Sezgi C, Sen H, Kaya H, Kucukoner M, Kaplan MA, Celik Y, Senyigit A.

Eur Rev Med Pharmacol Sci. 2013 Jan;17(1):19-24.

16.

[Prognostic factors in non-small cell lung cancer patients and prognostic importance of PET/CT SUV max value].

Erdem V, Selimoğlu Şen H, Kömek H, Tanrikulu AC, Abakay A, Sezgi C, Kaya H, Senyiğit A.

Tuberk Toraks. 2012;60(3):207-17. Turkish.

17.

The incidence of mesothelioma has not decreased for the last twenty years in Southeast region of Anatolia.

Carkanat AI, Abdurrahman A, Abakay O, Cengizhan S, Selimoglu SH, Senyigit A.

Afr Health Sci. 2011 Sep;11(3):346-52.

18.

[A new alternative treatment in COPD: phosphodiesterase-4 inhibitors].

Sezgi C, Şenyiğit A.

Tuberk Toraks. 2011;59(3):285-90. Review. Turkish.

19.

Clinical characteristics and treatment outcomes in 132 patients with malignant mesothelioma.

Abakay A, Tanrikulu AC, Kaplan MA, Kucukoner M, Abakay O, Sen H, Isikdogan A, Senyigit A.

Lung India. 2011 Oct;28(4):267-71. doi: 10.4103/0970-2113.85688.

20.

Clinical and demographic characteristics of tracheobronchial variations.

Abakay A, Tanrikulu AC, Sen HS, Abakay O, Aydin A, Carkanat AI, Senyigit A.

Lung India. 2011 Jul;28(3):180-3. doi: 10.4103/0970-2113.83973.

21.

Unusual combination of tracheobronchopathia osteochondroplastica and AA amyloidosis.

Kirbaş G, Dağli CE, Tanrikulu AC, Yildiz F, Bükte Y, Senyiğit A, Kiyan E.

Yonsei Med J. 2009 Oct 31;50(5):721-4. doi: 10.3349/ymj.2009.50.5.721. Epub 2009 Oct 21.

22.

Co-existince of sickle cell disease and hemidiaphragm paralysis.

Babayiğit C, Melek IM, Duman T, Senyiğit A, Gali E.

Tuberk Toraks. 2006;54(4):378-81.

PMID:
17203426
23.

Environmental malignant pleural mesothelioma in Southeast Turkey.

Tanrikulu AC, Senyigit A, Dagli CE, Babayigit C, Abakay A.

Saudi Med J. 2006 Oct;27(10):1605-7. No abstract available.

PMID:
17013496
24.

Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis.

Corut A, Senyigit A, Ugur SA, Altin S, Ozcelik U, Calisir H, Yildirim Z, Gocmen A, Tolun A.

Am J Hum Genet. 2006 Oct;79(4):650-6. Epub 2006 Aug 29.

25.

Determination of environmental exposure to asbestos (tremolite) and mesothelioma risks in the southeastern region of Turkey.

Senyigit A, Dalgic A, Kavak O, Tanrikulu AC.

Arch Environ Health. 2004 Dec;59(12):658-62.

PMID:
16789474
26.

Follow-up results in tuberculous cervical lymphadenitis.

Oktay MF, Topcu I, Senyigit A, Bilici A, Arslan A, Cureoglu S, Yildirim M.

J Laryngol Otol. 2006 Feb;120(2):129-32. Epub 2005 Nov 25.

PMID:
16359138
27.

The results of rehabilitation on motor and functional improvement of the spinal tuberculosis.

Nas K, Kemaloğlu MS, Cevik R, Ceviz A, Necmioğlu S, Bükte Y, Cosut A, Senyiğit A, Gür A, Saraç AJ, Ozkan U, Kirbaş G.

Joint Bone Spine. 2004 Jul;71(4):312-6.

PMID:
15288857
28.

Pulmonary alveolar microlithiasis: a rare familial inheritance with report of six cases in a family. Contribution of six new cases to the number of case reports in Turkey.

Senyiğit A, Yaramiş A, Gürkan F, Kirbaş G, Büyükbayram H, Nazaroğlu H, Alp MN, Topçu F.

Respiration. 2001;68(2):204-9.

PMID:
11287838
29.
30.

Malignant pleural mesothelioma caused by environmental exposure to asbestos in the Southeast of Turkey: CT findings in 117 patients.

Senyiğit A, Bayram H, Babayiğit C, Topçu F, Nazaroğlu H, Bilici A, Leblebici IH.

Respiration. 2000;67(6):615-22.

PMID:
11124643
31.

Incidence of malignant pleural mesothelioma due to environmental asbestos fiber exposure in the southeast of Turkey.

Senyiğit A, Babayiğit C, Gökirmak M, Topçu F, Asan E, Coşkunsel M, Işik R, Ertem M.

Respiration. 2000;67(6):610-4.

PMID:
11124642
32.

High-resolution computed tomography in cases with environmental exposure to asbestos in Turkey.

Topçu F, Bayram H, Simşek M, Kaya K, Ozcan C, Işik R, Senyiğit A.

Respiration. 2000;67(2):139-45.

PMID:
10773784

Supplemental Content

Loading ...
Support Center